GMAB vs LQDA
Genmab A/S vs Liquidia Corporation — AI-powered side-by-side comparison
VS
LQDA
Liquidia Corporation
68
Buy
| Metric | GMAB | LQDA |
|---|
| AI Score |
60
|
68
|
| Price |
$30.82
|
$88.09
|
| P/E Ratio |
24.04×
|
368.26×
|
| ROE |
16.5%
|
-154.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
39.9%
|
91.8%
|
| Debt / Equity |
0.89×
|
1.70×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
72.5
|
55.0
|
| Beta |
0.685
|
0.572
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for GMAB versus LQDA.
LQDA leads by 8 points.
LQDA scores 68/100 (Buy) versus GMAB at 60/100 (Buy).
GMAB Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- EPS declining -25.3% YoY despite any revenue growth — Growth
- RSI at 73 is in overbought territory — Technical
LQDA Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 46.8% shows genuine earnings power backing the valuation — Value
- Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 362.9 is expensive by classic value standards — Value
- Price-to-book of 12.9x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical